|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-9-16
|
|
pubmed:abstractText |
The paper provides the data available in the literature on the present-day direction in exploitation of recombinant vaccines on the basis of Mycobacterium spp. Special attention is paid to the nature of shuttle vectors for Mycobacterium spp. and E. coli.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0869-6047
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7688618-Bacterial Vaccines,
pubmed-meshheading:7688618-DNA, Bacterial,
pubmed-meshheading:7688618-DNA, Recombinant,
pubmed-meshheading:7688618-Drug Design,
pubmed-meshheading:7688618-Genetic Techniques,
pubmed-meshheading:7688618-Genetic Vectors,
pubmed-meshheading:7688618-Mycobacterium,
pubmed-meshheading:7688618-Plasmids,
pubmed-meshheading:7688618-Vaccines, Attenuated,
pubmed-meshheading:7688618-Vaccines, Synthetic
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
[The outlook for developing recombinant vaccines based on mycobacteria].
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|
